Tandem Diabetes Care, Inc. TNDM

15.72 0.50 3.29% as of 25 Sep
Market cap
$1.1B
P/E
0.0×
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 0.00 0.00 627.17 0.00 0.00 0.00 0.00 0.00
P/S ratio
1.46 2.51 2.46 3.57 13.49 11.70 9.63 9.94 0.13 0.76
P/FCF ratio
0.00 0.00 0.00 380.50 107.95 0.00 156.46 0.00 0.00 0.00
P/Operating CF
151.08 219.98 (255.07) 491.12 482.95 382.98 179.38 129.30 (1.24) (4.73)
P/B ratio
9.53 8.96 5.87 6.50 21.89 15.93 17.89 13.92 0.00 0.00
Price to Tangible BV
9.85 9.13 5.96 6.57 22.25 16.32 17.96 14.04 0.00 0.00
EV/Sales
1.47 2.37 2.22 3.15 13.01 11.13 9.18 9.66 0.71 1.04
EV/EBITDA
0.00 0.00 0.00 0.00 236.86 491.73 0.00 0.00 0.00 0.00
EV/Operating CF
(153.92) 91.95 (52.11) 50.03 82.08 225.12 79.35 (213.43) (1.16) (1.43)
EV/FCF
(15.13) (34.69) (19.87) 336.09 104.05 (728.34) 149.17 (156.04) (1.07) (1.25)
Quick Ratio
1.89 2.24 2.94 4.43 5.57 5.46 2.24 2.48 0.97 2.12
Current Ratio
2.55 2.93 3.83 5.14 6.15 6.14 2.78 2.83 1.78 2.93
Net Debt/EBITDA
(0.10) 1.57 0.86 4.61 (8.87) (24.96) 14.49 3.53 (1.11) (0.32)
Debt/Assets
35.19% 31.86% 29.92% 26.90% 31.10% 28.33% 4.29% 0.00% 80.28% 70.25%
Debt/Equity
2.00 1.17 0.91 0.64 0.65 0.55 0.07 0.00 (2.63) (13.32)
Asset Turnover
1.10 0.98 0.75 0.82 0.87 0.96 1.36 1.22 1.04 0.71
Operating CF/Net income
0.05 (0.25) 0.14 (0.53) 7.15 (0.72) (1.69) 0.07 0.91 0.73
Capex/Depreciation
(1.27) (4.01) (2.40) (2.10) (1.48) (1.68) (3.55) (0.37) (0.83) (1.65)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(97.88%) (33.30%) (59.08%) (21.67%) 3.89% (12.25%) (15.17%) (240.11%) 416.44% (290.04%)
ROA
(22.15%) (10.00%) (22.20%) (9.66%) 1.92% (6.60%) (9.30%) (81.30%) (70.31%) (70.38%)
ROIC
(67.83%) (46.57%) (111.48%) (54.60%) 15.60% (5.90%) (32.14%) (1,240.85%) (118.44%) (278.83%)
Return on Tangible Assets
(44.60%) (17.28%) (35.38%) (12.56%) 2.13% (5.89%) (11.81%) (88.37%) (153.10%) (105.60%)
Average Days of Receivables
59.53 44.48 51.53 52.26 57.51 60.14 46.93 69.86 70.53 48.40
Research and Development Expense of Revenue
26.44% 21.15% 33.22% 21.24% 13.10% 12.74% 12.48% 15.90% 19.20% 22.33%
Selling, General and Administrative Expense of Revenue
43.85% 41.46% 47.14% 41.90% 37.21% 41.08% 45.74% 57.23% 80.28% 98.32%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.01 0.01 0.00 0.00 0.02 0.02
Share Based Compensation of Revenue
9.10% 10.78% 11.78% 10.60% 8.64% 11.71% 16.03% 12.91% 11.74% 13.84%
Graham Net Nets
(0.07) 0.01 0.06 0.08 0.04 0.05 0.04 0.06 (4.18) (0.41)
Graham Number
0.00 0.00 0.00 0.00 6.09 0.00 0.00 0.00 43.29 34.51
Earnings Yield
(13.97%) (4.05%) (12.14%) (3.30%) 0.16% (0.61%) (0.74%) (9.35%) (638.58%) (130.00%)
Free Cash Flow Yield
(6.69%) (2.72%) (4.53%) 0.26% 0.93% (0.13%) 0.64% (0.62%) (498.82%) (109.32%)
Revenue per Share
15.08 14.37 11.51 12.49 11.16 8.18 6.19 3.82 18.95 27.56
Operating CF per Share
(0.14) 0.37 (0.49) 0.79 1.77 0.40 0.72 (0.17) (11.65) (20.01)
Capex per Share
(0.30) (1.00) (0.79) (0.67) (0.37) (0.53) (0.33) (0.06) (1.01) (2.92)
Free Cash Flow per Share
(0.44) (0.63) (1.28) 0.12 1.39 (0.12) 0.38 (0.23) (12.66) (22.93)
Cash per Share
4.35 6.70 7.20 9.62 9.90 7.95 3.02 2.68 2.50 18.17
Shareholders Equity per Share
2.31 4.02 4.83 6.86 6.87 6.01 3.33 2.73 (5.13) (1.94)
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
2.31 4.02 4.83 6.86 6.87 6.01 3.33 2.73 (5.13) (1.94)
Free Cash Flow
(29.67) (41.41) (83.41) 7.51 87.85 (7.62) 22.37 (11.30) (71.85) (70.10)
Working Capital
375.42 477.44 552.73 684.69 679.66 533.38 176.75 121.60 28.07 60.62
Capital Expenditures
(19.95) (65.63) (51.60) (42.95) (23.51) (32.29) (19.54) (2.99) (5.72) (8.93)
Net Current Asset Value
(107.80) 19.93 108.96 237.14 339.50 287.13 145.01 112.87 (60.34) (26.23)
EV/EBIT
0.00 0.00 0.00 0.00 403.50 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.02 0.07 0.07 0.05 0.03 0.06 0.05 0.02 0.05 0.11
Net Profit Margin
(20.17%) (10.21%) (29.77%) (11.81%) 2.21% (6.89%) (6.83%) (66.68%) (67.87%) (99.05%)
Price to Operating Income
0.00 0.00 0.00 0.00 418.61 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.19 0.21 0.28 0.30 0.32 0.38 0.17 0.47 0.35 0.29
Cash ROIC
(12.31%) (5.34%) (10.16%) (1.35%) 4.56% (2.40%) 2.33% (9.78%) (139.30%) (61.90%)
Accounts Receivable Turnover
7.25 8.54 6.79 7.11 7.29 7.75 8.86 6.57 6.73 6.68
Accounts Payable Turnover
10.21 9.56 7.22 9.27 14.25 13.41 13.68 15.71 10.03 9.52
Inventory Turnover
3.37 2.93 2.82 4.32 4.94 4.23 4.87 4.01 2.64 3.13
Average Days of Payables
36.65 36.23 47.63 52.40 31.33 27.27 38.53 26.49 29.60 45.21
Days of Inventory on Hand
100.27 121.18 151.69 104.47 76.61 97.60 106.56 77.22 155.14 127.54
Average Receivables
140.04 110.07 110.14 112.72 96.46 64.39 40.89 27.99 15.98 12.61
Average Payables
45.90 47.16 52.66 41.88 22.92 17.78 12.28 5.99 6.33 6.37
Average Inventory
139.19 153.77 134.53 89.83 66.14 56.40 34.48 23.44 24.09 19.37
Average Assets
924.39 960.16 1,002.72 978.96 810.78 521.26 266.20 150.82 103.87 118.56
Average Common Equity
209.13 288.37 376.79 436.53 399.71 280.64 163.13 51.06 (17.54) 28.77

Fold the line items

Columns are period end dates